Consequently, we developed an experimental model for the generation of autologous antigen-specific vitD3-tolDC and T cells from healthy donors, using an immunogenic peptide presented via class II MHC with the aim to reproduce antigen presentation in the context of CD4+-mediated autoimmune diseases. This evidence concerns the gene CD4 and autoimmune disease.